Documents
Application Sponsors
ANDA 209018 | PERRIGO UK FINCO | |
Marketing Status
Application Products
001 | GEL;TOPICAL | 0.015% | 0 | INGENOL MEBUTATE | INGENOL MEBUTATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-01-07 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2021-03-05 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2021-03-19 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 2 | Null | 15 |
SUPPL | 3 | Null | 15 |
TE Codes
CDER Filings
PERRIGO UK FINCO
cder:Array
(
[0] => Array
(
[ApplNo] => 209018
[companyName] => PERRIGO UK FINCO
[docInserts] => ["",""]
[products] => [{"drugName":"INGENOL MEBUTATE","activeIngredients":"INGENOL MEBUTATE","strength":"0.015%","dosageForm":"GEL;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"01\/07\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/209018Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"08\/26\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert, Labeling-Patient Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2020-08-26
)
)